Patent protection for ZORYVE cream 0.3% extends until at least 2037. ZORYVE cream 0.3% is indicated for the topical treatment of plaque psoriasis, including intertriginous areas, in adult and ...
Home Instead — a franchise company with one of the largest home care footprint in the U.S. — has made major moves to bring on ...